| Grant Number |
PI Name |
Project Title |
| 5P50MH066171-040001 |
ABI-DARGHAM, ANISSA |
PREFRONTAL
DOPAMINE FUNCTION IN SCHIZOPHRENIA |
| 5P50MH066171-049003 |
ABI-DARGHAM, ANISSA |
CORE--CLINICAL |
| 5R01DA015806-03 |
ABI-DARGHAM, ANISSA |
PET
Imaging of Serotonin Transmission in MDMA Users |
| 1R01DA022455-01A1 |
ABI-DARGHAM, ANISSA |
Imaging
dopamine transmission in cannabis dependence |
| 1R01DA020647-01A2 |
AHARONOVICH, EFRAT |
Modified
Behavioral Treatment for Cocaine Patients with Cognitive Deficits |
| 1R21DA021122-01A2 |
AIDALA, ANGELA |
Drug
Abuse, Mental Illness, Homelessness, and HIV: Evaluating Models of Care |
| 5U01MH064092-06 |
ALBANO, ANNE |
Child/Adolescent
Anxiety Multimodal Treatment Study (CAMS) |
| 5R21MH069868-03 |
ATTIA, EVELYN |
Atypical
Antipsychotic Medication in Anorexia Nervosa |
| 5R34MH070597-03 |
ATTIA, EVELYN |
Anorexia
Nervosa: The Importance of Treatment Intensity |
| 1R21MH080024-01 |
BANTA, SCOTT |
Delivery
Systems for Precision Brain Cell Targeting |
| 5R01DA006600-15 |
BARR, GORDON |
Opiate
Withdrawal & Tolerance: Development & Plasticity |
| 5R01MH080603-02 |
BARR, GORDON |
Amygdala
Gene Expression: Learning in a Sensitive Period |
| 5P50MH066171-049002 |
BEGG, MELISSA |
CORE--BIOSTATISTICS
AND DATA MANAGEMENT |
| 1K08DA016396-01A2 |
BERMAN, JOSHUA |
Interactions
of Stress and Nicotine |
| 5R01DA015822-03 |
BISAGA, ADAM |
Memantine
Naltrexone Treatment for Opioid Dependence |
| 5R01DA017572-05 |
BISAGA, ADAM |
Developing
Medication For Tobacco Addiction: NMDA Agents |
| 3R01DA019606-01A2S1 |
BLANCO, CARLOS |
Substance
Abuse in US Hispanics: A National Study |
| 5R01DA019606-02 |
BLANCO, CARLOS |
Substance
Abuse in US Hispanics: A National Study |
| 5R01DA020783-02 |
BLANCO, CARLOS |
SMART:
Improving Detection & Outcome of Psychiatric Comorbidity in Drug
Treatment |
| 1R01MH073595-01A1 |
BONANNO, GEORGE |
Cognitive
and Emotional Mechanisms in Chronic Grief |
| 1R03DA021108-01A1 |
BRISSON, ANNE |
HIV
Prevention with Heroin Using Women Sex Workers in Tajikistan |
| 5R01MH073080-02 |
BROWN, ALAN |
Prenatal
Factors and Risk of Bipolar Disorder |
| 5R01MH036295-22 |
BRUDER, GERARD |
BEHAVIORAL,
ERP AND EEG ASYMMETRY IN AFFECTIVE DISORDERS |
| 5R01MH066597-04 |
BRUDER, GERARD |
Subtypes
of Schizophrenia: ERPs During Memory Processing |
| 5R01HD046060-04 |
CARBALLO-DIEGUEZ, ALEX |
Topical
Microbicide Acceptability |
| 5R01MH073410-03 |
CARBALLO-DIEGUEZ, ALEX |
Predictors
of HIV Risk Behavior Among Men in Argentina |
| 1K23DA021850-01A1 |
CARPENTER, KENNETH |
An
Experimental Model of Human Language and Cognition in Drug Dependence |
| 1R01DA019399-01A1 |
CATON, CAROL |
HIV
Risk Among Homeless Mothers |
| 5R01MH060911-07 |
COHEN, PATRICIA |
Personality
Disorder Over 20yrs: Risks, Course & Impact |
| 5P50DA009236-140001 |
COMER, SANDRA |
Laboratory
Model for Heroin Abuse Medications |
| 5R01DA016759-05 |
COMER, SANDRA |
Precription
Opioid Effects in Drug and Non-drug Abusers |
| 1R01DA022222-01 |
COMER, SANDRA |
Sustained-Release
Naltrexone for Opioid Dependence: Longitudinal Study in Humans |
| 1R01DA023697-01A1 |
DAVIDSON, LESLIE |
Health
& Psychosocial Need: Children with Developmental Disorder in a Time of
HIV |
| 5R01AG021488-05 |
DEVANAND, DAVANGERE |
Antipsychotic
Discontinuation in Alzheimer s Disease |
| 1R01MH081948-01 |
DOWNEY, GERALDINE |
Rejection
sensitivity and self-regulation in personality disorders |
| 1K08MH079088-01 |
DRANOVSKY, ALEX |
The
contribution of adult-born neurons to hippocampal structure and connectivity. |
| 1R21HD056170-01 |
DUARTE, CRISTIANE |
Maternal
depression and child weight: Early pathways |
| 5P01NS048447-04 |
DUFF, KAREN |
Pathological
and Functional Impact of Tauopathy in vivo |
| 1K01MH071555-01A1 |
DULAWA, STEPHANIE |
Mechanism
of the antidepressant response in 5-HT1AR mice |
| 2R01MH060877-09A2 |
DWORK, ANDREW |
Myelin
Pathology in Schizophrenia |
| 1U49CE001247-01 |
EHRENSAFT, MIRIAM |
Can
Family Based Prevention of Conduct Problems Prevent IPV Development |
| 5P30MH043520-19 |
EHRHARDT, ANKE |
HIV
Center for Clinical and Behavioral Studies |
| 1R25MH080665-01 |
EL-BASSEL, NABILA |
HIV
Intervention Science Training Program for Minority New Investigators |
| 5R01MH023864-34 |
ENDICOTT, JEAN |
COLLABORATIVE
DEPRESSION STUDY |
| 5R01MH019560-33 |
ERLENMEYER-KIMLING, L |
A
PROSPECTIVE STUDY OF CHILDREN OF SCHIZOPHRENIC PARENTS |
| 5R01DA009114-12 |
EVANS, SUZETTE |
Vulnerability
to Anxiolytic Abuse in Women |
| 1R01DA022218-01 |
EVANS, SUZETTE |
Progesterone
Treatment for Cocaine-Dependent Women |
| 1R01DA021242-01A2 |
EVANS, SUZETTE |
Sex
Differences in Stress & Impulsivity in Cocaine Abusers |
| 5R01MH074370-03 |
EXNER, THERESA |
A
Structural Intervention to Enhance Women's Health |
| 5R01MH071456-02 |
FALLON, BRIAN |
Treatment
of Hypochondriasis with CBT &/or SSRI |
| 5R01MH059244-09 |
FERRERA, VINCENT |
Attention
and Voluntary Action in Prefrontal Cortex |
| 1R21MH073821-01A1 |
FERRERA, VINCENT |
Functional
Imaging of Decision Networks |
| 5R13MH058769-09 |
FIFER, WILLIAM |
Meeting
of the International Society for Developmental Psychobiology |
| 5R13MH058769-10 |
FIFER, WILLIAM |
Meeting
of the International Society for Developmental Psychobiology |
| 5R37HD032774-11 |
FIFER, WILLIAM |
Perinatal
Assessment of At-Risk Populations |
| 5R21MH078575-02 |
FISHER, PRUDENCE |
Computerized
Screen for Adverse Events Associated with SSRI's in Youth |
| 2R01DA004130-19A2 |
FOLTIN, RICHARD |
Anorectic
Drugs: Abuse and Behavioral Mechanisms of Action |
| 5R01DA008105-14 |
FOLTIN, RICHARD |
Laboratory
Analysis of Cocaine Abstinence |
| 1R01DA021319-01A1 |
FOLTIN, RICHARD |
Translational
Approach to Models in Relapse |
| 5R01AG005213-19 |
FRIEDMAN, DAVID |
Effects
of Age on the Cognitive ERPD/Cardiac Waveffect |
| 5R01HD014959-21 |
FRIEDMAN, DAVID |
Maturation
of Cognitive-Related Brain Potentials |
| 1R01DA019964-01 |
FULLER, CRYSTAL |
Social
Predictors for Transition into Injection Drug Use |
| 1R01MH079488-01A1 |
FYER, ABBY |
OCD
Collaborative Genetics Association Study |
| 1K25MH074068-01A2 |
GALFALVY, HANGA |
Statistical
Methods for Predicting Sucicide Attempt |
| 5R01MH076026-02 |
GINGRICH, JAY |
Gene-Environment
Interactions and Vulnerability to Neuropsychiatric Disorders |
| 1R01MH077235-01A1 |
GOGOS, JOSEPH |
Elucidation
of gene networks underlying susceptibility to schizophrenia |
| 1R01MH080234-01A1 |
GOGOS, JOSEPH |
Elucidating
the effect of Disc1 on neurodevelopment and synaptic transmission |
| 5R01EY014978-05 |
GOLDBERG, MICHAEL |
The
Neurophysiology of Spatial Vision |
| 1R01DA020892-01 |
GOODWIN, RENEE |
Role
of depression and anxiety in the tobacco epidemic |
| 5R01EY014697-05 |
GOTTLIEB, JACQUELINE |
Parietal
mechanisms of vision and attention |
| 5U01MH060903-07 |
GREENHILL, LAURENCE |
Follow-up
of the PATS Sample |
| 5U10MH066762-05 |
GREENHILL, LAURENCE |
RUPP-PI
in New York City |
| 1K23MH076049-01 |
GRUNEBAUM, MICHAEL |
Fluoxetine/Bupropion
Suicide Attempters Major Depressive |
| 1R34MH078719-01A1 |
GUILAMO-RAMOS, VINCENT |
Reducing
Teen Risky Behavior: A Clinic-Based Approach |
| 1K23DA020000-01 |
GUNDERSON, ERIK |
Buprenorphine
for Opioid Dependence in Primary Care |
| 5P50MH066171-040003 |
HABER, SUZANNE |
ANATOMY
OF DA SYSTEMS REGULATIONS IN PRIMATES |
| 7R01MH074118-03 |
HAGHIGHI, FATEMEH |
An
Integrated Framework of Epigenomics and Human Disease |
| 1R01MH074118-01 |
HAGHIGHI, FATEMEH |
An
Integrated Framework of Epigenomics and Human Disease |
| 5P50DA009236-140008 |
HANEY, MARGARET |
Pharmacological
Treatment of Marijuana Dependence |
| 5R01DA019239-04 |
HANEY, MARGARET |
Medication
Development for Marijuana Relapse |
| 5R01DA003476-22 |
HART, CARL |
Drug
Effects on Behavior: Workplace Implications |
| 5R01DA019559-03 |
HART, CARL |
Intranasal
Methamphetamine: A Pharmacotherapy Model |
| 5R01AA013654-05 |
HASIN, DEBORAH |
Alcohol
in Israel: Genetic and Environmental Effects |
| 5R01AA014323-03 |
HASIN, DEBORAH |
Reducing
Unsafe Drinking in HIV Primary Care |
| 5R01DA018652-04 |
HASIN, DEBORAH |
Phenotypes
for Drug Abuse:Epidemiologic-Genetic Approach |
| 5R01NS045108-05 |
HAWKINS, ROBERT |
Aggregation
of presynaptic proteins during LTP |
| 5P50MH066171-049005 |
HEN, RENE |
CORE--MOLECULAR
AND CELLULAR |
| 5R01MH068542-05 |
HEN, RENE |
Cellular
Mechanisms of Antidepressant Action |
| 1R01AA014341-01A2 |
HIEN, DENISE |
Combined
Treatment of Alcohol-Dependent Women with PTSD |
| 1R01DA023733-01A2 |
HOVEN, CHRISTINA |
Maternal
Incarceration and Course of Child Psychopathology in the South Bronx |
| 5R01HD046786-02 |
HOVEN, CHRISTINA |
Violence
and Mental Health: Children of First Responders |
| 1R03MH073728-01A1 |
ISETT, KIMBERLEY |
Integration
Difusion for SMI Service Delivery |
| 5R01DA011495-10 |
JAVITCH, JONATHAN |
DOPAMINE
TRANSPORTER: SUBSTRATE & COCAINE BINDING SITES |
| 7R01MH054137-12 |
JAVITCH, JONATHAN |
Structure
of the Dopamine D2-Like Receptor Binding Sites |
| 1K05DA022413-01A1 |
JAVITCH, JONATHAN |
Molecular
Determinants for the Action of Psychostimulants |
| 5P50MH066171-040004 |
JAVITT, DANIEL |
DOPAMINE
IN A PRIMATE MODEL OF GLUTAMATE HYPOFUNCTION |
| 5P30MH071478-049002 |
JENSEN, PETER |
Core--Research
Network Development |
| 1R01MH075026-01 |
JU, JINGYUE |
Gene
Expression Analysis of Aplysia Neural Network |
| 5P50MH066171-040005 |
KANDEL, ERIC |
MOUSE
MODELS OF DA AND GLUTAMATE DYSFUNCTION |
| 1K23MH077653-01A1 |
KIMHY, DAVID |
Psychosis
in Schizophrenia: Mechanisms of Recovery |
| 5P50DA009236-14 |
KLEBER, HERBERT |
Novel
Medication Approaches for Substance Abuse |
| 5P50DA009236-149001 |
KLEBER, HERBERT |
Core--Biostatistics/Training
and Education |
| 1K23MH071285-01A1 |
KLEIN, DIANE |
Excitatory
Controls of Eating in Eating Disorders |
| 5R01HG004214-02 |
KLITZMAN, ROBERT |
Views
and Approaches Toward Research Integrity Among IRBs |
| 5P50DA009236-140006 |
LARUELLE, MARC |
Mesolimbic
DA D1/D2 Receptors and Response to Cocaine |
| 5P50MH066171-040002 |
LARUELLE, MARC |
SUBCORTICAL
DA FUNCTION IN SCHIZOPHRENIA |
| 1K08MH076083-01A1 |
LEONARDO, EDUARDO |
Hippocampal
Neurogenesis: Mechanisms of Antidepressant Action |
| 5P50DA009236-140009 |
LEVIN, FRANCES |
Agonist
Treatment for Marijuana Dependence |
| 5R01DA015451-04 |
LEVIN, FRANCES |
Marijuana
Dependence & Depression: Venlafaxine Treatment |
| 5R01DA022217-02 |
LEVIN, FRANCES |
Combined
Pharmacotherapies for Cocaine Dependence |
| 1R01DA023652-01 |
LEVIN, FRANCES |
Extended
Release Mixed Amphetamine Salts for Adult ADHD and Cocaine Dependence |
| 1R01MH077226-01A2 |
LEWIS-FERNANDEZ, ROBERTO |
Motivational
Antidepressant Therapy for Hispanics |
| 5R34MH073087-03 |
LEWIS-FERNANDEZ, ROBERTO |
Culturally
Congruent Program of MDD Care for Hispanics |
| 5P50MH066171-04 |
LIEBERMAN, JEFFREY |
Neurobiology
of Dopamine in Schizophrenia |
| 1U01MH076544-01 |
LIEBERMAN, JEFFREY |
Pharmacologic
and Clinical Testing of a D1 Agonist for Neuropsychiatric Disorders |
| 5R01MH064726-04 |
LIEBOWITZ, MICHAEL |
CBT
Augmentation of Paroxetine for Social Anxiety |
| 1R21MH074996-01A1 |
LINK, BRUCE |
Stigma
and Psychosis: A Prospective Study |
| 5R01MH060884-08 |
LISANBY, SARAH |
Magnetic
Stimulation Therapy: A New Convulsive Treatment |
| 5R01MH069895-04 |
LISANBY, SARAH |
Optimization
of TMS for Depression |
| 1R21MH077161-01 |
MAJO, VATTOLY |
Development
of Agonist PET Probes for Quantifying 5-HT1A Receptor Binding |
| 5P50MH062185-08 |
MANN, JOSEPH |
The
Neurobiology of Suicidal Behavior |
| 5R01MH056390-10 |
MANN, JOSEPH |
Familial
Pathways to Early-OnSet Suicide Attempts |
| 5R01HD046351-04 |
MANTELL, JOANNE |
Female
Condom Use in South African College Students |
| 1R01MH078770-01A1 |
MANTELL, JOANNE |
A
Structural Intervention To Integrate Reproductive Health Into HIV Care |
| 1K23DA021209-01 |
MARIANI, JOHN |
Anticonvulsant
Pharmacotherapy for Sedative-Hypnotic Use Disorders |
| 1K01MH077652-01 |
MARSH, RACHEL |
Self-Regulatory
Control and Habit Learning in Adolescents with Bulimia Nervosa |
| 5R01MH068173-04 |
MARSHALL, RANDALL |
Combination
Treatment for PTSD After the WTC Attack |
| 5R01DA016788-03 |
MARTINEZ, DIANA |
PET
Imaging of Mesolimbic Dopamine in Heroin Dependence |
| 3R01DA016788-03S1 |
MARTINEZ, DIANA |
PET
Imaging of Mesolimbic Dopamine in Heroin Dependence |
| 5R01DA020855-03 |
MARTINEZ, DIANA |
Imaging
the Neurobiology of a Behavioral Treatment |
| 5R33DA016183-05 |
MARTINEZ, DIANA |
Kappa
receptor selective PET ligands |
| 5R03DK066033-02 |
MAYER, LAUREL |
Does
Metabolic Syndrome Exist in Anorexia Nervosa? |
| 1R03MH076343-01 |
MAYER, THOMAS |
Cellular
Assay:Presentation of the Adhesion Molecul(RMI) |
| 1R03MH076344-01 |
MAYER, THOMAS |
Cellular
Assay:TNF Alpha Induced NF Kappa B Translo(RMI) |
| 1R03MH076509-01 |
MAYER, THOMAS |
Assay:TNF
Alpha Induced E-Selectin Expression(RMI) |
| 1R34MH073651-01 |
MCALLISTER, WILLIAM |
Services
Research Innovations for Homeless Mentally Ill |
| 5R01MH069133-04 |
MELLINS, CLAUDE |
Mental
Health and Risk in HIV+ Youth and Seroreverters |
| 1K08MH076258-01A1 |
MILAK, MATE |
Characterization
Novel 5-HT1A Receptor Agonist PET |
| 1R34MH072838-01 |
MONK, CATHERINE |
Therapy
for Prenatal Depression:Maternal & Fetal Effects |
| 5P50MH066171-049001 |
MOORE, HOLLY |
CORE--NEUROCHEMISTRY |
| 5R01AA015553-02 |
MORGENSTERN, JON |
Naltrexone
and CBT for problem drinking |
| 5R01DA015971-06 |
MORGENSTERN, JON |
Club
Drug Use and Risky Behaviors Among Men |
| 1R21AA017135-01 |
MORGENSTERN, JON |
Component
Analysis of Motivational Interviewing |
| 1R01MH073640-01 |
MUFSON, LAURA |
Group
IPT-A in School-Based Clinics |
| 1R56MH082537-01 |
|
Effectiveness
of Suicide Hotline Training and Assessment of Usage Patterns |
| 1R01DA024001-01 |
|
A
Molecular Analysis of the Gateway Hypothesis in Mice |
| 1K08MH068762-01A2 |
NARENDRAN, RAJESH |
Imaging
dopamine-2 (D2) receptor sites in schizophrenia |
| 5R01MH072833-03 |
NERIA, YUVAL |
Long-Term
Impact of WTC Attacks in Primary Care |
| 5P50DA009236-140003 |
NUNES, EDWARD |
New
Approaches to Cocaine Abuse Medications |
| 5R01DA010746-10 |
NUNES, EDWARD |
Opiate
Dependence: Combined Naltrexone/Behavior Therapy |
| 5R01DA016950-04 |
NUNES, EDWARD |
MI
Training: Live Supervision by Tele-Conference |
| 3U10DA013035-05S4 |
NUNES, EDWARD |
CU
PARTNERS: NY/LONG ISLAND REGIONAL NODE |
| 2U10DA013035-06 |
NUNES, EDWARD |
Clinical
Trials Network: Long Island Regional Node |
| 1K24DA022412-01 |
NUNES, EDWARD |
Drug
Abuse Treatment Development and Research Mentoring |
| 1R01DA022541-01 |
OCHSNER, KEVIN |
The
Neural Bases of Affect Regulation in Drug Abuse |
| 1R01MH076137-01A1 |
OCHSNER, KEVIN |
The
Neural Bases of the Cognitive Control of Emotion |
| 1R34MH077156-01A2 |
PAPP, LASZLO |
Development
of Multimodal Treatment for Late Life Generalized Anxiety Disorder |
| 5R34MH078700-02 |
PAPPADOPULOS, ELIZABETH |
ADHD
Medication Adherence: A Parent-Provider Intervention Modeled From HIV |
| 1R01MH074813-01A1 |
PARSEY, RAMIN |
Biological
Predictors of Response to Antidepressants |
| 1R03MH076502-01 |
PAUMET, FABIENNE |
Unraveling
the Molecular Mechanisms of Phagocytosis(RMI) |
| 5R01DA017820-04 |
PETERSON, BRADLEY |
MRI
of Infants Exposed Prenatally to Drugs of Abuse |
| 5R01MH068318-04 |
PETERSON, BRADLEY |
Neuroanatomical
MRI Studies of Childhood Disorders |
| 1K02MH074677-01 |
PETERSON, BRADLEY |
MRI
IN CHILDHOOD NEUROPSYCHIATRIC DISORDERS |
| 1R01MH079162-01A1 |
PHELAN, JO |
Mental-illness
stigma and status processes in interpersonal interactions |
| 1K01MH081787-01 |
PINTO, ROGERIO |
Promoting
Community Collaboration in HIV Research |
| 5R01EY016270-12 |
QIAN, NING |
Computation
and Psychophysics of Motion and Stereopsis |
| 5R01MH072383-03 |
RABKIN, JUDITH |
Modafinil
Treatment for Fatigue in HIV+ Patients |
| 5P50MH066171-040006 |
RAYPORT, STEPHEN |
ETIOLOGIC
PATHWAYS TO DOPAMINE DYSFUNCTION |
| 5R01DA017978-03 |
RAYPORT, STEPHEN |
Transgenic
analysis of glutamate in sensitization |
| 1K01DA022282-01 |
REED, STEPHANIE |
Sex
Differences & Impulsivity: Effect of Drug History & Stimulant
Administration |
| 1R34MH082654-01 |
REMIEN, ROBERT |
A
Multimedia Social Support Intervention: Adherence to HIV Care in South Africa |
| 5R01NS022061-22 |
ROLE, LORNA |
Modulation
of Neuronal Acetylcholine Receptors |
| 1R03MH076348-01 |
ROTHMAN, JAMES |
Aggregation
and Clearance of Mutant Huntingtin(RMI) |
| 1R03MH076384-01 |
ROTHMAN, JAMES |
Regulation
of Neurotransmitter Transporter Recyclin(RMI) |
| 1R01DA020656-01A2 |
SALZMAN, C |
Neural
Mechanisms Underlying Reinforcement Learning |
| 2R01MH060387-06A2 |
SCHACHER, SAMUEL |
Mechanisms
Mediating Long-Term Synaptic Plasticity |
| 1R01DA020844-01A1 |
SCHEIFFELE, PETER |
Regulation
of growth and pruning of neuronal arbors |
| 1R01DA017721-01A1 |
SCHINKE, STEVEN |
Drug
Abuse Prevention: Mother-Daughter Intervention |
| 5R01MH056123-10 |
SCHMAUSS, CLAUDIA |
D3
pre-mRNA processing in chronic psychosis |
| 1R21MH077976-01A1 |
SCHNEIER, FRANKLIN |
Neural
circuitry of submissive behavior and treatment response in social anxiety |
| 5P30MH071478-04 |
SHAFFER, DAVID |
ACISR
for Pediatric Psychiatry Disorders |
| 5P30MH071478-049003 |
SHAFFER, DAVID |
Core--Research
Methods |
| 5R21MH077863-02 |
SHAIR, HARRY |
Formation
of Infant/Father Social Relationship |
| 1R01MH070741-01A2 |
SHEAR, M |
Complicated
Grief Treatment in Elderly Adults |
| 1R01MH076680-01A2 |
SIEGEL, KAROLYNN |
MSMW:
Pathways, Motives and Behaviors |
| 1R01MH075045-01A2 |
SILVER, RAE |
SCN
networks and efferent signals |
| 5R01MH045436-14 |
SIMPSON, HELEN |
Maximizing
Treatment Outcome in OCD |
| 5R34MH071570-02 |
SIMPSON, HELEN |
Enhancing
CBT Adherence in OCD with MI |
| 1R01MH073915-01A2 |
SIMPSON, HELEN |
Imaging
the Serotonin System in Obsessive-Compulsive Disorder |
| 5R01MH050839-12 |
SKODOL, ANDREW |
COLLABORATIVE
LONGITUDINAL STUDY OF PERSONALITY DISORDER |
| 5P50MH066171-049004 |
SLIFSTEIN, MARK |
CORE--BRAIN
IMAGING |
| 1K23MH075006-01A1 |
SNEED, JOEL |
Vascular
depression: A distinct diagnostic entity? |
| 5R01MH069915-03 |
SPINELLI, MARGARET |
Antepartum
Interpersonal Psychotherapy at 3 NYC Sites |
| 1R21MH076475-01 |
SSEWAMALA, FRED |
Asset-Ownership
Development Among HIV-Orphaned Children |
| 1K23MH076976-01A1 |
STANFORD, ARIELLE |
Negative
Symptoms of Schizophrenia: From Phenomenology to Targeted Treatment |
| 5P20AA015630-04 |
STANLEY, BARBARA |
DCIPS:
Intervention with High Suicide Risk Individuals |
| 3P20AA015630-04S1 |
STANLEY, BARBARA |
DCIPS:
Intervention with High Suicide Risk Individuals |
| 5R01MH062665-05 |
STANLEY, BARBARA |
Prospective
Study of Suicidal Behavior in BPD |
| 1R01MH082736-01 |
STEINGLASS, JOANNA |
Addressing
Fear of Food in Anorexia Nervosa |
| 1K23MH076195-01A2 |
STEINGLASS, JOANNA |
Cognitive
Neuroscience of Anorexia Nervosa |
| 1R01MH076961-01A2 |
STEWART, JONATHAN |
Combining
Antidepressants to Hasten Remission from Depression |
| 1R03MH082369-01A1 |
STOCKWELL, BRENT |
Luciferase
Screen for MDM2 E3 Ligase Inhibitors |
| 5R01DA020448-03 |
SULLIVAN, MARIA |
Predictors
of Relapse to Prescription Opioid Abuse Among Pain Patients |
| 3R01DA020448-03S1 |
SULLIVAN, MARIA |
Predictors
of Relapse to Prescription Opioid Abuse Among Pain Patients |
| 1K01DA019933-01A1 |
VADHAN, NEHAL |
Neuropsychological
Effects of Binge-Smoked Cocaine |
| 1K23MH071530-01A1 |
VERDELI, HELEN |
Prevention
for Symptomatic Offspring of Biopolar Parents |
| 1R01MH076136-01A1 |
WAGER, TOR |
The
neural bases of placebo effects and their relation to regulatory processes |
| 5R01MH065163-06 |
WAINBERG, MILTON |
RCT
of a Brazilian HIV Prevention Intervention for the SMI |
| 1R21DK074503-01A1 |
WALSH, B. |
The
Development of An Eating Laboratory for Overweight Adolescents |
| 5R21MH065024-05 |
WALSH, B. |
Translational
Research on Eating Disorders |
| 5U79SM057433-03 |
WASSERMAN, GAIL |
New
York State Youth Suicide Prevention |
| 5P30MH071478-049001 |
WEISSMAN, MYRNA |
Core--Principle
Research |
| 3R01MH060912-06S1 |
WEISSMAN, MYRNA |
Genetics
of Early-Onset Major Depression |
| 5R01MH060912-07 |
WEISSMAN, MYRNA |
Genetics
of Early-Onset Major Depression |
| 1R01MH082255-01 |
WEISSMAN, MYRNA |
Parental
Remission from Depression and Child Psychopathology |
| 5R01MH071751-02 |
WIEDENMAYER, CHRISTOPH |
The
prefrontal cortex: responses to threat in early life |
| 5R21MH073994-02 |
WIEDENMAYER, CHRISTOPH |
Fear
memory formation in early life |
| 7K23DA020487-03 |
WISDOM, JENNIFER |
Adolescent
Recovery From Drug Abuse During Transitions in Care |
| 1R01MH080659-01A1 |
WITTE, SUSAN |
Using
Multimedia Technologies to Disseminate an HIV Prevention Intervention |
| 1R21AA016286-01A1 |
WITTE, SUSAN |
HIV/STI
Prevention among Alcohol-Abusing Women in Mongolia |
| 1R01DA019496-01A1 |
WU, ELWIN |
Service
Use, ATI Program Outcomes, and Pro-Social Change |
| 5R01DA017776-02 |
WU, PING |
Adolescent
Use of Substance Use Treatment Services |
| 1R01DA020733-01A1 |
WU, PING |
Ecstasy
"Epidemic" and Youth: Trends, Comorbidity, Risk and Protective
Factors |
| 1K01MH073034-01 |
YANG, LAWRENCE |
EE
and Stigma among Chinese-Americans with Schizophrenia |
| 1R03MH076402-01 |
ZHOU, MING |
Molecule
Modulators:Voltage-Dependent Potassium (RMI) |